Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Diagnosis of Cutaneous Lymphoma

Diagnosing Cutaneous Lymphoma

How is cutaneous lymphoma identified?

In addition to a medical history and physical examination, a doctor may order a biopsy of a skin tumor or lymph node to confirm the diagnosis. A biopsy is a procedure in which tissue samples are removed (with a needle or during surgery) from the body for examination under a microscope to determine if cancer or other abnormal cells are present. The bone marrow and blood may also be sampled to look for lymphoma cells to help determine the stage if the disease.

Additional imaging testing with PET and/or CT scanning may be required to evaluate internal involvement. Molecular diagnostic techniques are frequently employed by our pathology services to assist in the diagnosis of cutaneous lymphoma.

INTERESTED IN AN ONLINE SECOND OPINION?

The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely, and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!

Visit our online second opinion page to learn more.

Condition Spotlight

Youn Kim, MD: Why I Went into Medicine Watch Video
News Updates Mycosis Fungoides: A Rash that Can Be Cancer Watch Video

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Clinics for Diagnosis